Maple & Ash's Ground-Floor Bar Unveils an Omakase That Leaves The Rules Behind

Chef Danny Grant and the team behind Maple & Ash have big plans for Eight Bar, the tavern underneath the Gold Coast steak house. They want the first floor to carve its own identity and see potential in opening other locations as they did earlier this year in Miami when Maple & Ash entered the South Beach market.
Maple & Ash's playful approach has proved successful, a consumer-first approach to fine dining centered around steaks without adhering to old rules. Management is trying to bring that energy downstairs at Eight Bar without the need for reservations, a requisite for Maple & Ash. One of Eight Bar's strengths is that a customer can find variety. They can order a burger accompanied by a maki roll with a glass of burgundy without judgment.
Seeing a greater opportunity, Eight Bar is giving sushi lovers a new omakase option, one that doesn't require reservations. 'Omakase' means 'chef's whim,' and Grant wants to give the power back to his diners. Eight Ball's Golden Omakase offering is the Japanese counterpart to Maple & Ash's popular 'I Don't Give a F@ck,' a $225 per person tasting menu option.
The $150 Golden Omakase is more of a 'customer's whim' — diners can decide on the spot.. It's meant to break rules, not beholden to tradition: 'I didn't want it to be a drag-out two-and-a-half-hour experience,' Grant says.
That's not to say the menu is amateurish. Hari Chan, a sushi chef who's spent more than a decade in Chicago behind restaurants like Kaze and Macku — before working for companies including Lettuce Entertain You Enterprises and Hogsalt — is ensuring Eight Bar's menu matches the standards he's set at his previous establishments. The menu isn't 100 percent sushi. Grant describes a scallop dish slow-roasted with ramps and left in the shell. For maki fans, one of the popular items is a King crab roll. An optional beverage pairing costs $75.
Diners can expect about seven courses. Grant says they check in with diners around course five to see how they're doing. Grant says that they don't want customers to feel like they need a slice of pizza at the end of their meal, but they also don't want to overstuff them.
Hearty eaters may earn a surprise at the end of their meals — if they have room in their stomachs. Grant teases a fried chicken sandwich: 'So it's not typical,' he says.
Maple & Ash opened in 2015 in the Gold Coast near two of Chicago's most beloved steakhouses, Morton's and Gibsons. The restaurant ascended thanks to its reverent attitude and lavish buildout. The restaurant has survived despite an acrimonious split with ownership. A group of the restaurant's former investors has also taken ownership to court with a laundry list of accusations.
Now dubbed Maple Hospitality, the reformed company is pursuing expansion opportunities, including a space in New York.
Sign up for our newsletter.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Associated Press

19 minutes ago

• Associated Press

Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

OSAKA, Japan & BOSTON--(BUSINESS WIRE)--Jun 23, 2025-- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; 'Ono') and Vertex Pharmaceuticals Incorporated (Headquarters: Boston, MA, U.S.; CEO: Reshma Kewalramani, M.D.; 'Vertex') today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex's povetacicept in Japan and South Korea. Povetacicept is a recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines with best-in-class potential being studied for the treatment of immunoglobulin A nephropathy (IgAN), primary membranous nephropathy (pMN) and other serious B cell-mediated diseases. Under the terms of the agreement, Ono will pay Vertex an upfront payment, as well as certain regulatory and commercial milestone payments and tiered royalties. Ono will utilize its extensive development expertise to help advance Vertex's clinical trials for povetacicept and will be responsible for obtaining marketing authorizations in Japan and South Korea. Following approval, Ono will be solely responsible for commercializing povetacicept in these regions. The agreement includes povetacicept for both IgAN and pMN, with the potential to add other indications. 'Vertex has a strong track record of developing innovative therapies for serious diseases. Through this strategic partnership, we can strengthen our late-stage pipeline in the immunology field, which is a key focus area for Ono,' said Toichi Takino, Representative Director, President and Chief Operating Officer of Ono. 'We look forward to collaborating with Vertex to provide this new therapeutic option for patients with IgAN and other autoimmune diseases in Japan and South Korea, and to maximize the value of this treatment.' 'Ono is a proven leader in Japan and South Korea, bringing established local relationships, infrastructure, and nephrology expertise that make them a perfect partner for Vertex as we look to deliver povetacicept to the thousands of potential patients in these countries,' said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. 'We are very pleased to partner with Ono and look forward to close collaboration as we continue to advance this potentially best-in-class treatment for IgAN, pMN and other serious B cell-mediated diseases.' The Phase 3 clinical trial is underway in multiple regions, including the U.S., EU and Asia. Specifically, Japanese and South Korean regulatory authorities have approved the Clinical Trial Application (CTA) for RAINIER, where the Phase 3 trial is underway. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 15 consecutive years on Science magazine's Top Employers list and one of Fortune's 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit or follow us on LinkedIn, Facebook, Instagram, YouTube and X. View source version on CONTACT: Ono Pharmaceutical Co., Ltd. Corporate Communications [email protected] more information: Vertex Pharmaceuticals Incorporated Investors: [email protected]: [email protected] or International: +44 20 3204 5275 or U.S.: 617-341-6992 or Heather Nichols: +1 617-839-3607 KEYWORD: NORTH AMERICA UNITED STATES SOUTH KOREA ASIA PACIFIC JAPAN MASSACHUSETTS INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH GENETICS PHARMACEUTICAL CLINICAL TRIALS SOURCE: Ono Pharmaceutical Co., Ltd. Copyright Business Wire 2025. PUB: 06/23/2025 04:00 AM/DISC: 06/23/2025 04:02 AM

CNBC

an hour ago

• CNBC

Dollar surge could be short-lived after U.S. strike on Iran

The U.S. dollar surged in early trading on Monday, benefiting from its traditional safe-haven status after U.S. military strikes on Iran — but analysts are warning the gains may be short-lived. The dollar index was up 0.45% at one point, indicating a gain against currencies such as the Japanese yen, the euro and the British pound, as well as the Canadian, Australian and New Zealand dollars. The greenback was last seen trading around 0.4% higher at 9.30 a.m. London time. "The escalation of the Middle East crisis after the US attacks Iran during the weekend is expected to lead to some of the traditional safe haven effects in the market [such] as the oil price is rising, lower equity prices and a stronger dollar," said Kirstine Kundby-Nielsen, fixed income and currency research at Danske Bank. Despite the initial rally, a growing consensus among investment banks suggests the dollar's strength may prove temporary. Some analysts say the Middle East conflict is merely masking concerns over U.S. fiscal policy, trade wars, and weakening international demand for U.S. assets, which are likely to regain focus once the immediate crisis-driven demand fades. The dollar index is down more than 8% this year, reflecting the long-term concern. The U.S. dollar's immediate strength is tied to fears of how Iran might retaliate, with a closure of the Strait of Hormuz — a waterway vital to the transit of oil — at the top of those concerns. Yet, RBC Capital Markets analysts caution that the situation is more complex, noting that Iran has asymmetric capabilities to "strike individual tankers and key ports." "Hence, we do not believe it is a 'full closure or nothing' scenario when it comes to the waterway, and Iran may deploy their asymmetric capabilities to raise the economic cost of the combined US/Israeli operations," said RBC's Halima Croft, a former CIA analyst, in a note to clients. Jordan Rochester, head of FICC strategy for the EMEA region at Mizuho, also expressed some optimism when it came to the possibility of a Strait of Hormuz closure. "It's a bold call but I doubt the strait of Hormuz is blocked and we avoid the $100-130pb oil levels touted by the sell side with Iranian allies such as China likely to be applying pressure to keep oil flows ongoing," he said in a Monday morning note. "The US is also likely to have made energy infrastructure a red line attached to its support of Israel." However, a key indicator of safe-haven demand — the U.S. Treasury market — appears to be telling an entirely different story through its unusually muted reaction. A global crisis typically sends investors flocking to U.S. government debt, but Danske Bank's Kundby-Nielsen said the "impact on US Treasuries is a bit more uncertain given the significant trade deficit and tariffs combined with a potential increase in the supply of Treasuries given the soft fiscal policy". A global trade war is compounding these fiscal concerns. With a July 9 deadline approaching until a reprieve on levies expires, the U.S. is threatening tariffs of up to 50% on most imports from the European Union. "As far as the USD goes, we'd suspect that the USD would be sinking lower if it weren't for the War, largely because the news pertaining to US import tariffs is not particularly good, and because data from outside the US, while weak, does not point to further deterioration relative to the US," said Thierry Wizman and Gareth Berry, Macquarie's currency and rates strategists, in a June 20 note to clients that preceded the U.S. strike on Iran. FX strategists from Bank of America also point out that investors are betting heavily on the decline of the U.S. dollar, which adds momentum to any downward move for the currency. According to the BofA global fund manager survey released on June 16, fund managers currently see short-U.S. dollar as the third most crowded trade — although the survey was carried out before to the United States' involvement in the Middle East conflict.

Newsweek

3 hours ago

• Newsweek

US Allies Ramp Up Sea Power as North Korea Threat Rises

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Japan and South Korea—both treaty allies of the United States in Northeast Asia—received new warships to bolster their sea power amid North Korea's ongoing naval modernization. Newsweek has contacted the North Korean Embassy in China for comment by email. Why It Matters North Korea—one of nine nuclear-armed countries—continues to threaten Japan and South Korea with the use of force. As part of its military buildup, Pyongyang has launched two 5,000-ton, missile-armed destroyers since April, with two sister ships planned for next year. Japan and South Korea possess advanced naval capabilities, making them key allies of the U.S. Navy. Tokyo is converting warships into aircraft carriers capable of deploying stealth fighter jets, while Seoul has outlined plans to build a vessel equipped with dozens of drones. What To Know The Japan Maritime Self-Defense Force announced that it held a delivery and ensign flag presentation ceremony at Mitsubishi Heavy Industries Maritime Systems' Tamano Shipyard on June 19, commissioning JS Yubetsu—the eighth Mogami-class frigate—into service. The Japanese frigate JS Yubetsu delivered to the Japan Maritime Self-Defense Force at Mitsubishi Heavy Industries Maritime Systems' Tamano Shipyard in Japan on June 19. The Japanese frigate JS Yubetsu delivered to the Japan Maritime Self-Defense Force at Mitsubishi Heavy Industries Maritime Systems' Tamano Shipyard in Japan on June 19. Japan Maritime Self-Defense Force The 3,900-ton warship is armed with missiles and a gun, and it is capable of conducting anti-ship, anti-submarine and naval mine warfare missions. Japan plans to acquire a total of 12 Mogami-class next-generation multi-mission frigates, according to the specialist outlet Naval News. The Yubetsu and the seventh ship of the Mogami-class, JS Niyodo, are the only two ships in the class equipped with a vertical launching system for firing missiles, Naval News reported, adding that the six earlier sister ships would be retrofitted with the same system later. Following the commissioning of the Japanese warship, South Korea's newest frigate, ROKS Gyeongbuk, was launched at SK Oceanplant's shipyard in Goseong on June 20. It is the second 3,600-ton vessel in the FFX Batch-III frigate program, according to Naval News. The South Korean navy described the Gyeongbuk as a "next-generation escort ship" designed to replace older frigates and patrol combat corvettes. It is expected to be delivered to the navy and become operational in June 2026 after completing tests and evaluations. SK Oceanplant launching the South Korean frigate ROKS Gyeongbuk at a shipyard in Goseong, South Korea, on June 20. SK Oceanplant launching the South Korean frigate ROKS Gyeongbuk at a shipyard in Goseong, South Korea, on June 20. South Korean Navy Similar to Japan's Mogami-class frigates, South Korea's FFX Batch-III frigates are armed with missiles and a gun to undertake a wide range of missions—including anti-ship, land-attack and anti-submarine warfare as well as defense against incoming anti-ship missiles. What People Are Saying The War Zone, a specialist outlet, said in a 2023 report on the Mogami-class frigates: "The Mogami class is capable of everything from surveillance to minesweeping operations as well as anti-surface, anti-air, and anti-submarine warfare. The frigates feature advanced electronic warfare and sensor suites. But above all else, they are designed to be operated by remarkably small crews. In essence, they will help the [Japan Maritime Self-Defense Force] to be able to do far more with far less." Admiral Yang Yong-mo, the chief of staff of the South Korean navy, said at the launching ceremony of ROKS Gyeongbuk on June 20: "The newly launched Gyeongbuk is a combat vessel that integrates Korea's outstanding shipbuilding technology and defense science and technology, equipped with cutting-edge combat systems and precise detection equipment we made ourselves, and powerful armaments that will carry out the mission of protecting national interests and the lives of our citizens at sea perfectly." What Happens Next While countering North Korea's growing naval capabilities, Japan and South Korea also face threats posed by China—which has the world's largest navy by hull count—as the East Asian power expands its naval presence in the waters surrounding its neighbors.